WSCM
COLL icon

Wellington Shields Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Wellington Shields Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8,000
Closed -$204K – 312
2018
Q1 		$204K Buy
+8,000
New +$191K 0.03% 311

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Wellington Shields Capital Management's COLL Position: Q2 2018 in Review

Wellington Shields Capital Management sold out of Collegium Pharmaceutical (COLL) in Q2 2018, closing a stake of 8,000 shares — an estimated $204K sold.

Wellington Shields Capital Management first reported a position in COLL in Q1 2018 and held it in 1 quarter. The position peaked at $204K in Q1 2018. 133 funds tracked by Wall St. Rank hold COLL as of Q2 2018.

  • Wellington Shields Capital Management reported no remaining Collegium Pharmaceutical position as of Q2 2018 after selling out during the quarter.
  • Wellington Shields Capital Management sold 8,000 Collegium Pharmaceutical shares in Q2 2018, an estimated $204K.
  • Wellington Shields Capital Management first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 1 quarter.
  • Wellington Shields Capital Management's Collegium Pharmaceutical position peaked at $204K in Q1 2018.
  • 133 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2018.

Based on Wellington Shields Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.